[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-343645-105":59,"doc-detail-343645-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","nitric-oxide-based-multi-synergistic-nanomedicine-an-emerging-therapeutic-for-anticancer","Nitric oxide-based multi-synergistic nanomedicine: an emerging therapeutic for anticancer","","Gas therapy has emerged as a promising approach for treating cancer, with gases like NO, H2S, and CO showing positive effects. Among these, NO is considered a key gas molecule with significant potential in stopping cancer progression. However, due to its high reactivity and short half-life, delivering NO directly to tumors is crucial. NO-driven nanomedicines (NONs) are reviewed, including donor types, action mechanisms, delivery systems, combination strategies, and clinical prospects and challenges.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/nitric-oxide-based-multi-synergistic-nanomedicine-an-emerging-therapeutic-for-anticancer/343645/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/nitric-oxide-based-multi-synergistic-nanomedicine-an-emerging-therapeutic-for-anticancer/343645.png","ImageObject",300,407,{"name":92,"@type":93},"Skyler","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-04","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":29},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"Why is delivering nitric oxide directly to tumors important?","Question",{"text":112,"@type":113},"NO is highly reactive and has a short half-life, so direct tumor delivery is necessary to achieve therapeutic effectiveness and support cancer treatment outcomes.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What does the review cover about NO-driven nanomedicines?",{"text":117,"@type":113},"It summarizes progress in NO-based cancer nanotherapeutics, including the types of NO donors, mechanisms of NO therapy, and delivery systems used to transport NO donors to tumors.",{"name":119,"@type":110,"acceptedAnswer":120},"How can NO donors be used to enhance cancer therapy?",{"text":121,"@type":113},"The review explores combining NO donors with other treatments to improve therapeutic efficacy, addressing ongoing and potential challenges and optimization directions for multisynergistic approaches.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},343645,1790734866,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":29,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},2336464648746,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","Tang et al. Journal of Nanobiotechnology (2024) 22:674  \n[https://doi.org/10.1186/s12951-024-02929-z](https://doi.org/10.1186/s12951-024-02929-z)  \nJournal of Nanobiotechnology  \n REVIEW Open Access  \nNitric oxide-based multi-synergistic nanomedicine: an emerging therapeutic for anticancer  \nYaqin Tang1,2, Qiyu Li1, Ziwei Zhou1, Huayang Bai1, Nianting Xiao1, Jing Xie1* and Chong Li2*  \nAbstract  \nGas therapy has emerged as a promising approach for treating cancer, with gases like NO, H2S, and CO showing positive effects. Among these, NO is considered a key gas molecule with significant potential in stopping cancer progression. However, due to its high reactivity and short half-life, delivering NO directly to tumors is crucial for enhancing cancer treatment. NO-driven nanomedicines (NONs) have been developed to effectively deliver NO donors to tumors, showing great progress in recent years. This review provides an overview of the latest advancements in NO-based cancer nanotherapeutics. It discusses the types of NO donors used in current research, the mechanisms of action behind NO therapy for cancer, and the different delivery systems for NO donors in nanotherapeutics. It also explores the potential of combining NO donors with other treatments for enhanced cancer therapy. Finally, it examines the future prospects and challenges of using NONs in clinical settings for cancer treatment.  \nHighlights  \n• A thorough and detailed overview of NO-based therapy, including information on its various donor types, mechanisms of NO release, and the underlying mechanisms of its anticancer effects.  \n• An overview of the NO-driven delivery system is provided, covering both covalent and non-covalent approaches, with a particular emphasis on the latest progress.  \n• This review delves into the current clinical treatments for cancer based on NO. It also highlights the ongoing and potential challenges in NO-driven anticancer therapy, along with discussions on optimizing advanced multisynergistic treatments for cancer.  \nKeywords Nitric oxide, Synergistic nanomedicine, Cancer therapy, Responsive nanoparticles  \n*Correspondence:  \nJing Xie [xiejing33@cqut.edu.cn](xiejing33@cqut.edu.cn)[ ](xiejing33@cqut.edu.cn)Chong Li [chongli@swu.edu.cn](chongli@swu.edu.cn)  \n© The Author(s) 2024. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creativecommons.org/licenses/by-nc-nd/4.0/](http://creativecommons.org/licenses/by-nc-nd/4.0/.)[.](http://creativecommons.org/licenses/by-nc-nd/4.0/.)  \nTang et al. Journal of Nanobiotechnology (2024) 22:674 Page 2 of 36  \nGraphical Abstract  \nBackground  \nCancer is a deadly disease with a low cure rate and high mortality rate, posing a serious threat to human health [1] . The exact causes of cancer, including external habits, environmental factors, genetic mutations, and other factors, are still not fully understood. Current clinical treatments for cancer include surgery, radiotherapy, and chemotherapy [2] . Surgery is often the preferred option for early-stage cancers, while palliative treatments are necess","cbCaihh0Ib9X9C8b","https://ap.wps.com/l/cbCaihh0Ib9X9C8b","pdf",5124545,36,"English","# Abstract\n# Highlights\n# Background\n## Overview of cancer and current clinical treatments\n## Multidrug resistance and limits of existing therapies\n# Gas therapy and the role of signaling gases\n## Development of gas therapy in cancer treatment\n## Biological functions of NO in anticancer mechanisms","[{\"question\":\"Why is delivering nitric oxide directly to tumors important?\",\"answer\":\"NO is highly reactive and has a short half-life, so direct tumor delivery is necessary to achieve therapeutic effectiveness and support cancer treatment outcomes.\"},{\"question\":\"What does the review cover about NO-driven nanomedicines?\",\"answer\":\"It summarizes progress in NO-based cancer nanotherapeutics, including the types of NO donors, mechanisms of NO therapy, and delivery systems used to transport NO donors to tumors.\"},{\"question\":\"How can NO donors be used to enhance cancer therapy?\",\"answer\":\"The review explores combining NO donors with other treatments to improve therapeutic efficacy, addressing ongoing and potential challenges and optimization directions for multisynergistic approaches.\"}]","Nitric oxide-based multi-synergistic nanomedicine: an emerging therapeutic for anticancer | PDF",1790051669,91,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a75392621d9bf7926580cc71f8fe5251.webp",983,1305,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3ddc7d75ccc068b33731d432394413f0.webp",982,1304,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0e0a0165c630ce57977030c9193483b8.webp",981,1303,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/bf1e6446e0fd0036bc040704b934c5ea.webp",980,1301]